What's in Lokien van Nunen's pipeline?

Lokien van Nunen has 4 drugs in our index: 0 marketed, 0 filed, 4 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Lokien van Nunen's portfolio?

Top competitors by shared drug class: Brigham and Women's Hospital, Inotek Pharmaceuticals Corporation, Pfizer Inc., University of Colorado, Denver.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/lokien-van-nunen.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Lokien van Nunen — Portfolio Competitive Intelligence Brief

Lokien van Nunen pipeline: 0 marketed, 0 filed, 4 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 4 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Regadenoson central - peripheral	Regadenoson central - peripheral	phase 3	Adenosine receptor agonist	A2A receptor	Cardiovascular
Regadenoson peripheral - central	Regadenoson peripheral - central	phase 3	Adenosine A2A receptor agonist	Adenosine A2A receptor	Cardiovascular
Regadenoson peripheral - peripheral	Regadenoson peripheral - peripheral	phase 3	Adenosine A2A receptor agonist	Adenosine A2A receptor	Cardiovascular
Regadenoson central -central	Regadenoson central -central	phase 3	A2A receptor agonist	A2A receptor	Cardiovascular

Therapeutic area mix

Cardiovascular · 4

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Brigham and Women's Hospital · 1 shared drug class
Inotek Pharmaceuticals Corporation · 1 shared drug class
Pfizer Inc. · 1 shared drug class
University of Colorado, Denver · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Lokien van Nunen:

Cite this brief

Drug Landscape (2026). Lokien van Nunen — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/lokien-van-nunen. Accessed 2026-05-16.